Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01518699 · ClinicalTrials.gov registry record · Phase 1
Study to Evaluate the Effect of Ha44 Gel on the Electrocardiogram in Healthy Volunteers
A Phase 1 study, sponsored by Dr. Reddy's Laboratories Limited.
- Completed
- Registry status
- Phase 1
- Development phase
- 57
- Enrollment target
NCT01518699 is a Phase 1 study that has completed, run by Dr. Reddy's Laboratories Limited. The registered enrollment target is 57 participants.
The verdict
NCT01518699, a Phase 1 study, has completed, sponsored by Dr. Reddy's Laboratories Limited.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 57 participants
- Enrollment target
Study Summary
The purpose of this study is to Evaluate the Effect of Ha44 Gel on the Electrocardiogram in Healthy Volunteers.
Interventions
- DRUG Moxifloxacin
- DRUG Moxifloxacin Placebo
- DRUG Ha44
- DRUG Ha44 Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2012-01 |
| Est. Completion | 2012-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01518699
The ClinicalTrials.gov registry entry for NCT01518699 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dr. Reddy's Laboratories Limited, which has 52 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Moxifloxacin is the first listed.
NCT01518699 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01518699 about?
NCT01518699 is a clinical study titled "Study to Evaluate the Effect of Ha44 Gel on the Electrocardiogram in Healthy Volunteers". The purpose of this study is to Evaluate the Effect of Ha44 Gel on the Electrocardiogram in Healthy Volunteers.
What is the current status of trial NCT01518699?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 57 participants. The study started on 2012-01. Estimated completion is 2012-05.
What interventions are being tested in trial NCT01518699?
The interventions under investigation include: Moxifloxacin (DRUG), Moxifloxacin Placebo (DRUG), Ha44 (DRUG), Ha44 Placebo (DRUG).
Who is sponsoring clinical trial NCT01518699?
This trial is sponsored by Dr. Reddy's Laboratories Limited, which has 52 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.